Director · ImmunityBio, Inc. · ImmunityBio, Inc. — Stock Option (right to buy)
Side
M
Value
—
Shares
25.0K
Price
—
Executed
Jan 20, 2026
Disclosed
Jan 21, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 20 executedJan 21, 2026 disclosed
IBRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 36.8% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Selecky Christobel filed this Form 4 reporting a option exercise of IBRX on Jan 20, 2026. It became public on Jan 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Selecky Christobelcik:0001849739
Issuer
ImmunityBio, Inc.cik:0001326110
Revision history · 0
No field has changed since this record was first ingested.
